GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN272201800011CHUMANETICS CORPORATION

Overview

Award facts

Net obligations
$10.30M
$10,299,171of $10.30M potential value
Outlays (paid to date)
$5.35M
$5.35M paid of $10.30M obligated$5,353,775
Period of performance
Mar 29, 2018 to Sep 30, 2025
Ended
Modifications
20
Latest action Mar 3, 2025
Contract type
Definitive contract
PIID HHSN272201800011C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS

Dates and value

Award date
Signed on Mar 29, 2018
Potential end of performance
Sep 29, 2025
Current value
$10,299,171Base and exercised options
Potential value (if all options are exercised)
$10,299,171

Obligations by fiscal year of action

  • FY2023: -$7 (de-obligation)
  • FY2021: $1,872,652
  • FY2020: $4,474,387
  • FY2019: $2,179,037
  • FY2018: $1,773,102

Total across 5 fiscal years: $10,299,171

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Mar 3, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationEDINA, MN
UEIMSRQYLLQLYQ5
CAGE code4B2E0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885); Nih office of the director (0846)Program activities075-0846, 075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Minneapolis, Hennepin County, Minnesota 55435-6012
Congressional district (place of performance)
MN-03As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
12

Solicitation and notices

Solicitation ID
HHSNIHNIAIDBAA20171(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Major program
An nhp efficacy study of bio 300 for mitigator for deare-induced pneumonitis and pulmonary fibrosis
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Mar 29, 2018Base obligation at award: $1,773,102
Latest action
Mar 3, 2025 — Other administrative actionModification P00020; administrative: no change in scope or value
Latest substantive action
Apr 23, 2021 — Option exercisedModification P00013; obligation change +$1,872,652
Latest funding action
Apr 5, 2023 — Funding onlyModification P00018; obligation change -$7; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action13
  • Option exercised3
  • Supplemental agreement (within scope)2
  • Funding only1
  • Change order1
21 actions recorded, Mar 29, 2018 to Mar 3, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
21

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2018/2018-0846-000
  • 075-2019/2019-0846-000
  • 075-2020/2020-0846-000
  • 075-2020/2024-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$4,513,701
COVID-19 supplemental outlays
$4,513,701